The ESOT Congress is the leading European meeting for the transplant community to share their expertise and latest research.


For this 20th anniversary meeting, we warmly welcome abstract submissions from:

Clinicians, Scientists, Researchers, Nurses and Allied Health Professionals

For the first time at the ESOT Congress, we invite clinicians to submit original and novel clinical cases that inspire new ideas and progress in transplantation.
A limited number of bursaries will be granted to the best abstracts submitted by young professionals (35 years old or less).


For Abstract and Clinical Case submissions



Deadline – Abstract Submission

22 Feb 2021


Opening for Clinical Case Submission

Opening Soon

Deadline for Clinical Case Submission

22 Feb 2021

Clinical Case Notification

20 May 2021

Abstract and Clinical Case
Submission Information

The ESOT Congress 2021 has introduced a number of new features to improve the abstract submission process, scroll down for details…

  • Five Congress domains have been introduced to address the most current issues in transplantation and show their transversal character. Each abstract submitter will be asked to indicate the most suitable track relating to their submission.
  • New categories for abstract submission have been added to the portfolio. They will focus on patient care, nursing and self-management. With these categories now included, ESOT welcomes further input and submissions from allied health professionals
  • A new abstract submission system, providing a more streamlined process for submitters, has been introduced. Submitters are asked to upload their abstracts as Word documents.
  • A limited number of bursaries will be granted to the best abstracts submitted by young professionals (35 years old or less). If you are eligible do not forget to apply for this during submission process.
  • ESOT will allow both original and encore abstracts, however only high quality original abstracts will be allocated to Full Oral sessions. 
  • Late-breaking abstract submission is available. However, a preliminary abstract will need to be submitted within the regular submission deadline (22 February 2021) to be considered.
  • Authors who receive a positive outcome of this initial review will then be required to submit a full abstract by the late-breaking submission deadline.
  • The late-breaking abstract submission deadline, under no circumstances, will be considered as an extension of the regular deadline.



For Abstract enquiries contact:

Justyna Klimek